System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.
E Sevene;
S Lewin;
A Mariano;
G Woelk;
AD Oxman;
S Matinhure;
J Cliff;
B Fernandes;
K Daniels;
(2005)
System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe.
BMJ, 331 (7519).
pp. 765-769.
ISSN 1468-5833
DOI: 10.1136/bmj.331.7519.765
Low cost and effective drugs, such as magnesium sulphate, need to be included in initiatives to improve access to essential medicines in Africa
Item Type | Article |
---|---|
ISI | 232417100027 |
Explore Further
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239984 (OA Location)
- 10.1136/bmj.331.7519.765 (DOI)
- 16195297 (PubMed)
Share this file
Downloads